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T cells. In conclusion, H. pylori shapes rather than suppresses human CD4
1 T-cell responses, and glucosylated cholesterol is a relevant bacterial component involved in this modulation.
Helicobacter pylori resides in one-half of the world's population and can cause gastritis, ulcer, and gastric cancer [1] . T-cell responses against H. pylori are associated with gastric inflammation [2, 3] and, in animal models, confer protection against infection [4, 5] . H. pylori virulence factors have evolved to suppress protective T-cell responses. The constitutively expressed enzyme c-glutamyl transpeptidase (GGT) is responsible for suppression of T cells [6] ; however, vacuolating exotoxin (VacA) has also been implicated in the inhibition of T-cell proliferation [7] . H. pylori has been shown to inhibit interleukin 2 (IL-2) secretion from human T-cell lines in a VacA-dependent manner, with modest effects in primary human T cells [8] . A third mechanism used by H. pylori has also been proposed: H. pylori is a cholesterol auxotroph and therefore extracts this essential nutrient from epithelial and antigen-presenting cells [9] . In a murine model of H. pylori infection, this process affected the immune response against the bacteria by promoting phagocytosis by antigen-presenting cells and thereby enhancing antigen-specific T-cell responses [9] .
T cells differentiate into diverse subsets upon activation by antigen-presenting cells [10] , including T-helper 1 (Th1), T-helper 2 (Th2), T-helper 17 (Th17), and T-regulatory (Treg) cells [11] . Th1 cells characteristically produce interferon c (IFN-c) and are important for immunity against intracellular microorganisms, whereas Th2 cells produce interleukin 4 (IL-4), interleukin 5 (IL-5), interleukin 10 (IL-10), and interleukin 13 and are linked to immune responses against extracellular pathogens. Cellular immune responses against H.
pylori are known to be predominantly mediated by Th1 cells [2] [3] [4] [5] . Th17 cells depend on transforming growth factor b (TGFb) and interleukin 6 (IL-6) for differentiation, produce interleukin 17A (IL-17A), and are important in the response to extracellular bacteria at mucosal surfaces, including H. pylori infection [12, 13] . Treg cells, which also require TGF-b for differentiation, are characterized by the expression of the transcription factor FoxP3 and their capacity to suppress immune responses [14] and are implicated in the persistence of H. pylori [15] .
Previous investigations into the effects of H. pylori on CD4
1
T cells have mainly used cell lines, even though these results may not be fully applicable to primary human T cells [8] . In addition, whereas the effect of purified molecules (eg, VacA and GGT) has been tested on T cells, little is understood about their contribution to the modulation of immunity by whole bacteria [7, 8] . Moreover, because most studies have focused on IL-2 secretion [6] [7] [8] , the effect of H. pylori on other cytokines remains poorly characterized. Finally, potential interactions between H. pylori virulence factors affecting T-cell immunity have not yet been addressed. In this study, we evaluate the interdependence of the effects of VacA, GGT, and cholesterol/cholesterol a-glucosides on primary T cells using live H. pylori and relevant mutants. Analyzing Th1-, Th2-, and Th17-associated cytokines and Treg subsets of human CD4
1 T cells and proliferation, we demonstrate that H. pylori shapes rather than simply suppresses immune responses and bacterial cholesterol content, and the ability to form cholesterol a-glucosides contribute to this process.
MATERIALS AND METHODS
Bacteria
CagPAI 1 H. pylori wild-type strain P12 is a clinical isolate, which has been described elsewhere [16] . H. pylori P12 wild type was cultured on horse serum agar plates supplemented with vancomycin (10 lg/mL). The isogenic P12 mutant strains H. pylori DvacA, H. pylori Dggt, and H. pylori D421 (lacking cholesterol a-glucosyl transferase) strains were cultivated on selective agar plates. Bacteria were incubated for 2 days before infection at 37°C in an incubator with 5% CO 2 and 5% O 2 .
Isolation of Primary Human CD4 1 T Cells
Peripheral blood mononuclear cells were obtained following approval of the ethical committee of the Charité and informed consent from healthy human donors as described elsewhere [17] . 
Measurement of Cytokine Levels
Secretion levels of IL-2, IL-10, and tumor necrosis factor a (TNF-a) were evaluated by the DuoSet enzyme-linked immunosorbent assay (ELISA) development system (R&D Systems). For measurement of IFN-c, IL-6, IL-4, and IL-17A levels, sandwich ELISAs were performed as suggested by the supplier (U-Cytech, the Netherlands). The TGF-b1 ELISA was purchased from Bender MedSystems. We mimicked the ability of H. pylori to obtain cholesterol from the membranes of host cells [9] by incubating the bacteria with cholesterol. The effect of cholesterol saturation in combination with VacA or GGT on IL-2 production and expression of its receptor CD25 in human CD4 1 T cells was assessed by ELISA and fluorescence-activated cell sorting (FACS), respectively. Cells obtained from healthy volunteers were incubated with H. pylori and then activated. Levels of IL-2 secretion after 24 hours by CD4 1 T cells from different donors not exposed to H. pylori ranged from 450 to 1300 pg/mL ( Figure 1 ). In comparison, levels of IL-2 production were significantly reduced upon incubation with H. pylori ( Figure 1A) ; however, coating H. pylori with cholesterol significantly attenuated this inhibition ( Figure 1A ). Isogenic mutants lacking VacA elicited a similar, albeit weaker, phenotype as the cholesterol-saturated H. pylori.
In agreement with previous studies [6] , mutants lacking GGT activity inhibited IL-2 production ( Figure 1A ). We also measured the expression of CD25, a component of the IL-2 receptor, upon exposure to cholesterol-saturated H. pylori or VacA or GGT mutants. FACS analysis revealed that, similar to IL-2 production, expression of CD25 after 24 hours was significantly reduced when T cells were incubated with wildtype H. pylori, but not cholesterol-coated H. pylori or the VacA or GGT mutant bacteria ( Figure 1B , upper panels). After 7 days of incubation, CD25 remained down-regulated in viable H. pylori-exposed T cells. This long-term effect was partially reverted by precoating the bacteria with cholesterol ( Figure 1B , lower panel). Consistent with the data from 24-hour incubation, expression of CD25 was also not reduced in cells incubated with VacA or GGT mutant bacteria for 7 days (Figure 1B, lower panel). H. pylori also hampered the up-regulation of CD69 ( Figure 1C ), another early activation marker transiently expressed upon stimulation of T cells [18] . Expression of CD69 was exclusively dependent on VacA, as its inhibition was reverted by neither cholesterol coating nor the absence of GGT ( Figure 1C ).
These effects were not due to differences in the ability of cholesterol-treated bacteria or mutants to interact with CD4 1 T cells or induce their apoptosis ( Figure 2 ; Table 1 ). Therefore, these results reveal that even though H. pylori inhibits IL-2 and/or IL-2 receptor expression via the action of VacA and GGT, their effect is dramatically modulated by bacterial cholesterol content. In contrast, the inhibition of CD69 is exclusively mediated by VacA. Figure 3) ; however, this was restored by coating the bacteria with cholesterol or in the absence of VacA and GGT ( Figure 3A) . Coating of H. pylori DvacA or H. pylori Dggt with cholesterol did not further alter the release of IL-10 (data not shown).
Gastric epithelial cells from healthy individuals have been shown to produce more IL-4 than cells from H. pylori-infected patients [20] . In accordance, levels of IL-4 released by stimulated CD4
1 T cells (2-33 pg/mL) were significantly suppressed in the presence of H. pylori. This suppression was reverted when CD4 1 T cells were incubated with cholesterolcoated H. pylori ( Figure 3B ). VacA seemed to have the most significant impact on the inhibition of IL-4 ( Figure 3B ), and accordingly, coating of H. pylori DvacA with cholesterol had no additional effect (data not shown). By contrast, the absence of GGT did not increase IL-4 levels ( Figure 3B ). These data show that H. pylori suppresses IL-4 production by CD4 1 T cells mainly in a VacA-dependent manner. Furthermore, the amplitude of this suppression is modulated by bacterial cholesterol content.
Mucosal inflammation in H. pylori infection correlates with Th1 T-cell signatures [21] , and IFN-c-producing T cells are involved in gastric epithelial cell cytotoxicity [22] . Levels of IFN-c secretion by CD4
1 T cells varied between 200 and 4500 pg/mL ( Figure 3C ). Cells from 1 donor did not release IFN-c upon stimulation. CD4 1 T cells incubated with H. pylori released less IFN-c than cells not exposed to the bacteria ( Figure 3C ). Suppression of IFN-c and IL-4, however, was less pronounced than that observed for IL-10 ( Figure 3A , B, and C). Interestingly, although the presence of VacA and GGT was required for the suppression of IFN-c, bacterial cholesterol content did not play any role. Production of TNF-a has been shown to correlate with gastritis and bacterial load in H. pylori-infected patients [23, 24] . In contrast to the effect of H. pylori on the other cytokines studied here, exposure of CD4 1 T cells to the bacterium did not modulate the secretion of this pro-inflammatory cytokine. Under all conditions, cells released TNF-a levels of 395-2, 820 pg/mL ( Figure 3 ). Our results show that H. pylori can suppress anti-inflammatory and pro-inflammatory cytokine production. However, modulation of the latter type is often less pronounced or may not occur. Bacterial cholesterol content affects the amplitude of the inhibition of anti-inflammatory cytokines only, whereas VacA and GGT are involved in the inhibition of both types of cytokines. Previous work has shown that IL-17 is expressed at a higher level in the gastric mucosal and lamina propria of H. pyloriinfected patients [13] . By contrast, here we found that H. pylori did not significantly affect the level of IL-17A produced by activated human CD4 1 T cells (20-285 pg/mL) ( Figure 4 ).
Coating the bacteria with cholesterol or exposure to H. pylori VacA or GGT mutants did not alter the levels of IL-17A produced ( Figure 4A ). Because Th17 differentiation depends on TGF-b1 and IL-6 [11] , we also measured the production of these cytokines. TGF-b1 secretion ranged from 5 to 52 ng/mL; however, cells from 8 of 14 donors did not release detectable levels of TGF-b1 ( Figure 4B ). In the presence of H. pylori, production of TGF-b1 was completely abolished (Figure 4B ), an effect neither modulated by cholesterol coating of H. pylori nor dependent on VacA or GGT virulence factors ( Figure 4B ). Cells from 10 of 12 donors produced detectable levels of IL-6 upon activation ranging from 14 to 790 pg/mL. H. pylori enhanced the release of IL-6 under all conditions tested. Cholesterol coating or the absence of VacA or GGT had no effect on this H. pylorienhanced IL-6 secretion ( Figure 4C ). Moreover, despite proliferation of CD4 1 T cells being suppressed by the bacteria (see below), IL-6 levels were significantly increased after 7 days of incubation with H. pylori (data not shown). These data show that although IL-17A production, presumably by Th17 cells, is not modulated by H. pylori, T-cell-dependent TGF-b1 production was inhibited and IL-6 secretion was stimulated. In contrast to type 1 and 2 related cytokines, neither cholesterol coating nor VacA or GGT played a role in the modulation of TGF-b1 and IL-6, suggesting the existence of yet another set of factors targeting this arm of CD4
1 T-cell responses.
Cholesterol a-Glucosyltransferase-Deficient H. pylori at Low MOI Lack Antiproliferative Activity on Human T Cells
Previous work has implicated VacA and GGT in the H. pyloriinduced blockage of T-cell proliferation, the latter factor exerting a more potent effect [6, 7] . Given the modulation of GGT-and VacA-mediated effects on cytokines by bacterial cholesterol content, we determined whether cholesterol coating of H. pylori would alter the proliferation of human CD4 1 T cells. CFSEstained CD4 1 T cells were incubated with wild-type H. pylori or cholesterol-coated H. pylori prior to activation. In accordance with the results of previous work [25] , H. pylori inhibited proliferation of primary T cells; however, this effect was dependent on GGT but independent on VacA, contradicting results of previous studies that used purified VacA [7] ( Figure 5 ). Inhibition of T-cell proliferation was MOI-dependent, and consistent with our findings here, the effect of GGT was significantly modulated by bacterial cholesterol levels ( Figure 5C ), in particular at lower MOIs, which are probably more physiologically relevant. Most of the cholesterol H. pylori requires for optimal growth becomes glucosylated through the action of a cholesterol a-glucosyl transferase encoded by open reading frame HP0421 [26] . In a mouse model of H. pylori infection, HP0421-deficient mutants are readily phagocytosed by antigen-presenting cells enhancing proliferation of specific T cells [9] . Therefore, we measured the proliferation of T cells upon exposure to an isogenic H. pylori strain lacking cholesterol a-glucosyl transferase (H. pylori D421) [9] . At high MOIs, T-cell proliferation was strongly inhibited by the mutant; however, this inhibitory effect was rapidly attenuated as MOI decreased ( Figure 5B ). The mutation had an effect similar to coating wild-type bacteria with cholesterol ( Figure 5C ). However, coating H. pylori D421 with cholesterol did not modulate the inhibition of proliferation ( Figure 5C ). Similar results were obtained with a mutant of the gene HP0499, which Table 1 ).
is also involved in the synthesis of cholesterol a-glucosides [27] (data not shown). These data provide the first evidence that cholesterol a-glucosyl transferase activity is required for H. pylorimediated direct inhibition of human CD4
1 T-cell proliferation.
DISCUSSION
To date, 2 H. pylori virulence factors, VacA and GGT, have been implicated in directly suppressing human T cells. Purified VacA Human CD4 1 T cells were incubated with Helicobacter pylori, cholesterol-coated H. pylori (H. pylori CHOL), a mutant strain lacking cholesterol a-glucosyl transferase (H. pylori D421), cholesterol-coated H. pylori D421 (H. pylori D421 CHOL), a mutant strain lacking c-glutamyl transpeptidase (H. pylori Dggt), or a mutant strain lacking vacuolating exotoxin (H. pylori DvacA) at a multiplicity of infection of 50 for 2 hours and then activated with anti-CD3 and anti-CD28. Apoptosis was evaluated by fluorescence-activated cell sorting after 24 hours. No significant differences were found after treatment between H. pylori, H. pylori CHOL, and the mutants (analysis of variance test).
has been shown to inhibit IL-2 production in human [8] but not murine T cells [28] that lack a cognate receptor [29] . Although the cholesterol/cholesterol a-glucosyl content of the bacteria had a profound effect on antigen presentation and T-cell responses in mice [9] , its effect on human cells remained to be determined. Here, we demonstrate that bacterial cholesterol/cholesterol a-glucoside content constitute a third molecular component that synergises and/or modifies the activity of VacA and GGT to modulate human CD4 1 T-cell responses.
Previous studies of H. pylori factors that inhibited T-cell responses have focused on secreted molecules, such as VacA and GGT, reasoning these may preferentially be encountered by T cells in the inflamed gastric tissue. However, H. pylori is also present deeper within infected tissues [30] , and similar to other gram-negative bacteria, it sheds outer membrane vesicles. These vesicles are considered to be pathologically relevant mimicks of the bacterial membrane, carrying virulence factors [31] that can act at a distance [32, 33] . Thus, investigating the direct interaction of H. pylori with T cells at low MOIs using whole bacteria, as reported here, likely reflects physiological conditions. Conditioned culture supernatants containing GGT or recombinant GGT have been shown to abolish T-cell proliferation [6] , in a mechanism dependent on GGT enzymatic activity and, potentially, the modulation of the GTPase Ras signaling pathway, leading to cell cycle arrest. However, the process remains ill defined and may also be linked to the antiproliferative role proposed for endogenous human GGT expressed by activated T cells [34] . Our results confirmed and extended previous findings that GGT blocks proliferation but has little or no significant modulating activity on additional response parameters such as secretion of pro-and antiinflammatory cytokines. Furthermore, using whole mutant bacteria, we detected an additional inhibitory effect of GGT on CD25 expression. Most importantly, our findings indicate that the dramatic GGT-specific antiproliferative activity was subject to modulation by the bacterial cholesterol/cholesterol a-glucoside content, in particular at lower, likely more physiologically relevant MOIs. Cholesterol glucosides are thought to be characteristic of H. pylori because they are rarely found in other bacteria [35] . It has been proposed 1 T cells. Human CD4 1 T cells were incubated with Helicobacter pylori, cholesterol-coated H. pylori (H. pylori CHOL), a mutant strain lacking GGT (H. pylori Dggt), or a mutant strain lacking VacA (H. pylori DvacA) at a multiplicity of infection of 50 for 2 hours and then activated with anti-CD3 and anti-CD28. Supernatants were harvested after 24 hours, and the concentration of interleukin 17a (IL-17A) (A), transforming growth factor b1 (TGF-b1) (B), or interleukin 6 (IL-6) (C ) was evaluated by enzyme-linked immunosorbent assay. Data are the median percentage relative to uninfected cells. NA, not activated. *P , .05 (Mann-Whitney U test). ** P , .005, *** P , .001 that H. pylori controls the availability of cholesterol glucosilated phospholipids in the cell wall according to environmental changes [35] . Dendritic cell responses are modulated by H. pylori through phase variation of lipopolysaccharides [36] . Here, we show the first evidence that H. pylori directly manipulates host T-cell responses through changes in cholesterol/ cholesterol a-glucoside content.
Purified VacA also inhibits CD4
1 T-cell responses after polyclonal in vitro stimulation. This effect depends on the VacA allele present because only some forms bind to the leukocyte-specific receptor CD18 [29] . At high concentrations, VacA inhibited proliferation and expression of early surface activation markers such as CD25, as well as IL-2 production. Similar to cyclosporine or FK506, VacA inhibits the calcium-dependent activation of Figure 5 . Inhibition of T-cell proliferation by cholesterol a-glucosyltransferase from Helicobacter pylori. A, Carboxyfluorescein succinimidyl ester (CFSE)-stained human CD4 1 T cells were incubated with wild-type H. pylori, a mutant strain lacking c-glutamyl transpeptidase (H. pylori Dggt), or a mutant strain lacking vacuolating exotoxin (H. pylori DvacA) at a multiplicity of infection (MOI) of 50 for 2 hours and then activated with anti-CD3 and anti-CD28 for 7 days. Shown is a representative experiment of n 5 9. B, CFSE-stained human CD4
1 T cells were incubated with wild-type H. pylori or a mutant strain lacking cholesterol a-glucosyl transferase (H. pylori D421) at MOI of 10, 20, or 50 for 2 hours and then activated with anti-CD3 and anti-CD28 for 7 days. Shown is the percentage of proliferating cells for a representative experiment of n 5 9. C, CFSE-stained human CD4
1 T cells were incubated with wild-tye H. pylori or H. pylori D421 uncoated (upper panels) or coated with cholesterol (CHOL) (lower panels) at MOI of 10, 20, or 50 for 2 hours and then activated with anti-CD3 and anti-CD28 for 7 days. NA, not activated. Data are expressed as a percentage of proliferating cells. Upper panels, *P , .05, ***P , .001 (analysis of variance Tukey posttest); lower panels, *P , .05 (Wilcoxon test).
nuclear factor of activated T cells, a transcription factor that regulates the IL2 gene [37] . In our study, comparison of VacAdeficient mutants with parental bacteria expressing a CD18-binding VacA allele did not affect proliferation but the presence of VacA did result in reduced expression of CD25, CD69, and IL-2. In addition, we observed VacA-specific inhibition of IL-4, IL-10, and IFN-c production. With the exception of CD69, the extent of these inhibitory effects of VacA was again modulated by the bacterial cholesterol content.
IL-4 and IFN-c are often studied as surrogate markers of type 1 and type 2 T cell responses. Mucosal inflammation in mice is exacerbated in the absence of IL-4 [38] but correlates with Th1 T-cell signatures [21] . Furthermore, higher levels of IL-4 are produced by gastric epithelial cells from healthy individuals than those from H. pylori-infected patients [20] , and IFN-c-producing T cells are involved in gastric epithelial cell cytotoxicity [22] . Our data indicate that H. pylori interferes with IL-4 and IFN-c through the concerted action of VacA, GGT, and cholesterol/cholesterol a-glucosides. Recent studies suggested that Th17 cells and Treg cells also play important roles in H. pylori infection and immunity [13, 39, 40] . IL-17 was shown to be expressed at a higher level in the gastric mucosa and lamina propria of H. pylori-infected patients [13] , and H. pylori gastritis was associated with increased gastric mucosal production of IL-6 [41] . Moreover, levels of IL-6 in H. pylori-infected patients with early-stage gastric cancer decreased significantly after cure [24] . Therefore, we evaluated the effects of H. pylori on TGF-b, IL-6, and IL-17 levels. In our experiments, exposure of activated CD4 1 T cells to H. pylori did not change IL-17A expression but enhanced IL-6 production, whereas TGF-b levels became undetectable. Surprisingly, neither VacA, GGT, nor cholesterol/cholesterol a-glucoside levels had any influence on these changes. Thus, we propose that as yet unknown H. pylori factors interfere with these arms of the T-cell response. In summary, our data suggest that H. pylori shapes rather than simply suppresses or evades CD4
1 T-cell-mediated responses in order to persist within its host. The results of the present study establish that in addition to VacA and GGT, cholesterol/cholesterol a-glucosides and as yet unknown factors target specific aspects of T-cell responses (summarized in Table 2 ). The findings are consistent with previous observations that H. pylori supports T-cell-dependent inflammation by maintaining high levels of TNF-a and IL-17A while suppressing IL-10 and TGF-b.
In addition, up-regulation of IL-6 and down-regulation of IL-4 by H. pylori may be linked to the development of gastric cancer [24, 42, 43] , heart disease [44, 45] , and the inverse association between H. pylori infection and asthma [46] [47] [48] . Thus, the interplay between H. pylori and human CD4
1 T cells appears to be a key event in the establishment of a chronic infection that affects one-half of the world's population and is linked to a number of comorbidities [1] .
Notes
